Metabolic Screening

Allen, 1997, Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogester-one levels, J Pediatr, 130, 128, 10.1016/S0022-3476(97)70321-4 Allen, 1996, Newborn screening: Principles and practice, Adv Pediatr, 43, 231 1993, Newborn screening of congenital hypothyroidism: Recommended Guidelines, Pediatrics, 91, 1203, 10.1542/peds.91.6.1203 Aronson, 1990, Growth in children with congenital hypothyroidism detected by neonatal screening, J Pediatr, 116, 33, 10.1016/S0022-3476(05)81641-5 Buist, 1992, The practitioner’s role in newborn screening, Pediatr Clin North Am, 39, 199, 10.1016/S0031-3955(16)38291-8 Chaves-Carballo, 1992, Detection of inherited neurometabolic disorders: A practical clinical approach, Pediatr Clin North Am, 39, 101, 10.1016/S0031-3955(16)38376-6 Clayton, 1988, Dysmorphic syndromes with demonstrable biochemical abnormalities, J Med Genet, 25, 463, 10.1136/jmg.25.7.463 Clow, 1981, Outcome of early and long-term management of classical maple syrup urine disease, Pediatrics, 68, 856, 10.1542/peds.68.6.856 1992, Issues in newborn screening, Pediatrics, 89, 345 1982, New issues in newborn screening for phenylketonuria and congenital hypothyroidism, Pediatrics, 69, 104, 10.1542/peds.69.1.104 1980, Newborn screening fact sheets, Pediatrics, 83, 449 1996, Newborn screening fact sheets, Pediatrics, 98, 473, 10.1542/peds.98.3.473 Conrad, 1989, Safety of newborn discharge at less than 36 hours in an indigent population, Am J Dis Child, 43, 98 Coody, 1993, Early hospital discharge and the timing of newborn metabolic screening, Clin Pediatr, 32, 463, 10.1177/000992289303200804 Doherty, 1991, Detection of phenylketonuria in the very early newborn blood specimen, Pediatrics, 87, 240, 10.1542/peds.87.2.240 Drogari, 1987, Timing of strict diet in relationship to fetal damage in maternal phenylketonuria. An international collaborative study by the MRC/DHHS Phenylketonuria Register, Lancet, 2, 527 Eisensmith, 1996, Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern population, Pediatrics, 97, 512 Fischer, 1991, Management of congenital hypothyroidism, J Clin Endocrinol Metab, 72, 523, 10.1210/jcem-72-3-523 Fisher, 1989, Early treatment of congenital hypothyroidism. Experience and reason, Pediatrics, 83, 785, 10.1542/peds.83.5.785 Fost, 1993, Genetic diagnosis and treatment: Ethical considerations, Am J Dis Child, 147, 1190, 10.1001/archpedi.1993.02160350064009 Francois, 1994, Role of congenital hypothyroidism in hearing loss in children, J Pediatr, 124, 444, 10.1016/S0022-3476(94)70373-6 Fraser, 1986, Resistant ovary syndrome and premature ovarian failure in young women with galactosemia, Clin Reprod Fertil, 4, 133 Gaston, 1986, Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial, N Engl J Med, 314, 1593, 10.1056/NEJM198606193142501 Glorieux, 1988, Useful parameters to predict the eventual mental outcome of hypothyroid children, Pediatr Res, 24, 6, 10.1203/00006450-198807000-00003 Glorieux, 1992, Intellectual development at age 12 years of children with congenital hypothyroidism diagnosed by neonatal screening, J Pediatr, 121, 581, 10.1016/S0022-3476(05)81150-3 Goldsmith, 1973, Tyrosinemia with plantar and palmar keratosis and keratitis, J Pediatr, 83, 798, 10.1016/S0022-3476(73)80372-5 Goodman, 1994, Metabolic disorders of the newborn, Pediatr Rev, 15, 359 Gray, 1997, Failure to screen newborns for inborn errors: A potential consequence of changes in newborn care, Early Hum Dev, 48, 279, 10.1016/S0378-3782(96)01862-2 Gruters, 1992, Congenital hypothyroidism, Pediatr Ann, 21, 15, 10.3928/0090-4481-19920101-06 Guerina, 1994, Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection, N Engl J Med, 330, 1858, 10.1056/NEJM199406303302604 Guthrie, 1992, The origin of newborn screening, Screening, 1, 5, 10.1016/0925-6164(92)90025-Z Guthrie, 1963, A simple phenyulananine method for detecting phenyletonuria in large populations of newborn infants, Pediatrics, 32, 338, 10.1542/peds.32.3.338 Hammond, 1991, Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentration, N Engl J Med, 325, 769, 10.1056/NEJM199109123251104 Higginbottom, 1978, A syndrome of methylmalonic aciduria, homocystinuria, megaloblastic anemia and neurologic abnormalities in a vitamin B12-deficient breast-fed infant of a strict vegetarian, N Engl J Med, 299, 317, 10.1056/NEJM197808172990701 Hoff, 1988, Seroprevalence of human immunodeficiency virus among childbearing women: Estimation by testing samples of blood from newborns, N Engl J Med, 318, 525, 10.1056/NEJM198803033180901 Holme, 1992, Neonatal screen for hereditary tyrosinaemia type I, Lancet, 340, 850, 10.1016/0140-6736(92)92724-T Holtzman, 1986, Descriptive epidemiology of missed cases of phenylketonuria and congenital hypothyroidism, Pediatrics, 78, 553, 10.1542/peds.78.4.553 Irons, 1993, Screening for metabolic disorders: How are we doing?, Pediatr Clin North Am, 40, 1073, 10.1016/S0031-3955(16)38624-2 Kaplan, 1991, Intellectual outcome in children with maple syrup urine disease, J Pediatr, 119, 46, 10.1016/S0022-3476(05)81037-6 Koch, 1993, The North American collaborative study of maternal phenylketonuria: Status report 1993, Am J Dis Child, 147, 1224, 10.1001/archpedi.1993.02160350098015 Kvittingen, 1991, Tyrosinaemia type Iuan update, J Inherit Metab Dis, 14, 554, 10.1007/BF01797926 LaFranchi, 1985, Screening for congenital hypothyroidism with specimen collection at two time periods: Results of the northwest regional screening program, Pediatrics, 76, 734, 10.1542/peds.76.5.734 Lenke, 1980, Maternal phenylketonuria and hyperphenylalaninemia: An international survey of the outcome of untreated and treated pregnancies, N Engl J Med, 303, 1202, 10.1056/NEJM198011203032104 Levin, 1993, Cerebral edema in maple syrup urine disease, J Pediatr, 122, 167, 10.1016/S0022-3476(05)83521-8 Levy, 1994, Current approaches to genetic metabolic screening in newborns, Curr Opin Pediatr, 6, 707, 10.1097/00008480-199412000-00017 Levy, 1969, Transient tyrosinemia in full-term infants, JAMA, 209, 249, 10.1001/jama.1969.03160150035008 Lindstedt, 1992, Treatment of hereditary tyrosinaemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase, Lancet, 340, 813, 10.1016/0140-6736(92)92685-9 Lipson, 1980, Affinity of cystathionine β-synthase for pyridoxal 5’-phosphate in cultured cells: A mechanism for pyridoxine-responsive homocystinuria, J Clin Invest, 66, 188, 10.1172/JCI109843 Listemick, 1992, Delayed diagnosis of infants with abnormal neonatal screens, JAMA, 267, 1095, 10.1001/jama.1992.03480080065028 McCabe, 1983, Newborn screening for phenylketonuria: Predictive validity as a function of age, Pediatrics, 72, 390, 10.1542/peds.72.3.390 Meryash, 1981, Prospective study of early neonatal screening for phenylketonuria, N Engl J Med, 304, 294, 10.1056/NEJM198101293040510 Migeon, 1991, Congenital adrenal hyperplasia caused by 21-hydroxylase deficiency its molecular basis and its remaining therapeutic problems, Endocrinol Metab Clin North Am, 20, 277, 10.1016/S0889-8529(18)30269-X Minisymposium on tyrosinemia. Am J Hum Genet 47:302, 1990 Mitchell, 1990, Neurologic crises in hereditary tyrosinemia, N Engl J Med, 322, 432, 10.1056/NEJM199002153220704 Morris, 1994, Metabolic disorders in children, Curr Opin Neurol, 7, 535, 10.1097/00019052-199412000-00011 Mudd, 1985, The natural history of homocystinuria due to cystathionine β-synthase deficiency, Am J Hum Genet, 37, 1 Munnilch, 1992, Clinical aspects of midtochondrial disorders, J Inherit Metab Dis, 15, 444 National Committee for Clinical Laboratory Standards (NCCLS). Blood Collection on Filter Paper for Neonatal Screening Programs. Approved Standards. NCCLS Publication LA4-A. Villanova, PA, NCCLS, 1995 Nelson, 1991, Verbal dyspraxia in treated galactosemia, Pediatrics, 88, 346, 10.1542/peds.88.2.346 Pang, 1988, Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Pediatrics, 81, 866 Parris, 1982, Anesthetic considerations for the patient with homocystinuria, Anesth Analg, 61, 708, 10.1213/00000539-198208000-00018 Pittman, 1971, Hypothalamic hypothyroidism, N Engl J Med, 285, 844, 10.1056/NEJM197110072851508 Refsum, 1990, Clinical significance of pharmacological modulation of homocysteine metabolism, Trends Pharmacol Sei, 11, 411, 10.1016/0165-6147(90)90148-2 Riviello, 1991, Cerebral edema causing death in children with maple syrup urine disease, J Pediatr, 119, 42, 10.1016/S0022-3476(05)81036-4 Rovet, 1989, Effect of thyroid level on temperament in infants with congenital hypothyroidism detected by screening of neonates, J Pediatr, 114, 63, 10.1016/S0022-3476(89)80602-X Rubba, 1990, Early signs of vascular disease in homocystinuria: A noninvasive study by ultrasound methods in eight families with cystathionine-b-synthase deficiency, Metabolism, 39, 1191, 10.1016/0026-0495(90)90093-R Russo, 1990, Visceral pathology of hereditary tyrosinemia type I, Am J Hum Genet, 47, 317 Rutledge, 1990, Neonatal hemodialysis: Effective therapy for the encephalopathy of inborn errors of metabolism, J Pediatr, 116, 125, 10.1016/S0022-3476(05)81661-0 Saudubray, 1987, Hyperketotic states due to inherited defects of ketolysis, Enzyme, 38, 80, 10.1159/000469194 Schedewie, 1973, Skeletal findings in homocystinuria: A collaborative study, Pediatr Radiol, 1, 12, 10.1007/BF00972819 Scriver, 1997 Scriver, 1980, Phenylketonuria: Epitome of human biochemical genetics (first of two parts), N Engl J Med, 303, 1336, 10.1056/NEJM198012043032305 Scriver, 1980, Phenylketonuria: Epitome of human biochemical genetics (second of two parts), N Engl J Med, 303, 1394, 10.1056/NEJM198012113032404 Scriver, 1971, Thiamine-responsive maple-syrup-urine disease, Lancet, 1, 310, 10.1016/S0140-6736(71)91041-5 Sinai, 1995, Phenylketonuria screening: Effect of early newborn discharge, Pediatrics, 96, 605, 10.1542/peds.96.4.605 Sorenson, 1984, Parental response to repeat testing of infants with ‘false-positive’ results in a newborn screening program, Pediatrics, 73, 183, 10.1542/peds.73.2.183 Speiser, 1992, Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Invest, 90, 584, 10.1172/JCI115897 Sveger, 1976, Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants, N Engl J Med, 294, 1316, 10.1056/NEJM197606102942404 Tada, 1984, Follow-up study of a nation-wide neonatal metabolic screening program in Japan, Eur J Pediatr, 142, 204, 10.1007/BF00442450 Tharp, 1992, Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease, Pediatr Neurol, 8, 65, 10.1016/0887-8994(92)90056-5 Therrell, 1993 Thompson, 1989, Screening for congenital adrenal hyperplasia: Distribution of 17-hydroxyprogesterone concentrations in neonatal blood spot specimens, J Pediatr, 114, 400, 10.1016/S0022-3476(89)80557-8 Treacy, 1992, Maple syrup urine disease: Interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination, J Inherit Metab Dis, 15, 121, 10.1007/BF01800354 Vichinsky, 1988, Newborn screening for sickle cell disease: Effect on mortality, Pediatrics, 81, 749, 10.1542/peds.81.6.749 Waggoner, 1993, Long-term complications in treated galactosemia: 175 US cases, Int Pediatr, 8, 97 Waggoner, 1990, Long-term prognosis in galactosaemia: Results of a survey of 350 cases, J Inherit Metab Dis, 13, 802, 10.1007/BF01800204 Waisbren, 1983, Speech and language deficits in early treated children with galactosemia, J Pediatr, 102, 75, 10.1016/S0022-3476(83)80292-3 Walraven, 1995, Early newborn specimen: Survey of practices among newborn screening programs in the United States, Screening, 4, 1, 10.1016/0925-6164(95)00110-8 Weinberg, 1976, The occurrence of hepatoma in the chronic form of hereditary tyrosinemia, J Pediatr, 88, 434, 10.1016/S0022-3476(76)80259-4 Wilcken, 1995, Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babies, J Pediatr, 127, 965, 10.1016/S0022-3476(95)70040-4 Wilfond, 1993, National policy development for the clinical application of genetic diagnostic technologies, JAMA, 270, 2948, 10.1001/jama.1993.03510240060033 Wolf, 1985, Biotinidase deficiency: A novel vitamin recycling defect, J Inherit Metab Dis, 8, 53, 10.1007/BF01800660 Wolf, 1990, Screening for biotinidase deficiency in newborns: Worldwide experience, Pediatrics, 85, 512, 10.1542/peds.85.4.512 Wolf, 1985, Biotinidase deficiency: Initial clinical features and rapid diagnosis, Ann Neurol, 18, 614, 10.1002/ana.410180517